SET and non-small cell lung carcinoma: Furthermore, we found that SET-mediated PP2A inactivation may be responsible for the occurrence of chemoresistance in NSCLC cells, and additive knockdown of SET restored the sensitivity of NSCLC cells to paclitaxel.